Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
API
Manufacturing
89bio lines up BiBo Pharma to build $135M commercial API plant
89bio has struck a deal with China CDMO BiBo Pharma to build a plant which will produce bulk active ingredient for its MASH prospect pegozafermin.
Kevin Dunleavy
Apr 11, 2024 3:23pm
Teva reports revenue increase, says it will sell API business
Jan 31, 2024 11:11am
WuXi Biologics, WuXi AppTec plot expansions in US, China
Jan 8, 2024 12:11pm
EuroAPI adds to C-suite with Ludwig de Mot after fall shakeup
Jan 8, 2024 11:10am
Viatris to haul in $3.37B with 3 business divestures
Oct 2, 2023 4:49pm
AZ-Daiichi, Padcev, AbbVie—Fierce Pharma Asia
Sep 29, 2023 10:45am